Skip to main content

Table 2 Percentage description of type 2 diabetes (T2D), Impaired fasting glucose (IFG)/T2D, hypertension, waist-hip-ratio, waist circumference and body mass index by age group and by gender among 1623 study participants in Yaoundé, Cameroon, 2007

From: Risk factors of impaired fasting glucose and type 2 diabetes in Yaoundé, Cameroon: a cross sectional study

   Men (n = 666)   Women (n = 957)
   25-34 35-44 45-54 55-64 >65 p-value7   25-34 35-44 45-54 55-64 >65 p-value7
N 666 317 100 116 100 33   957 451 178 221 70 37  
Variable N (%) N (%) N (%) N (%) N (%) N (%)   N (%) N (%) N (%) N (%) N (%) N (%)  
T2D1 28 (4.2) 3 (10.7) 1 (3.6) 8 (28.6) 14 (50.0) 2 (7.1) <0.001 26 (2.7) 4 (15.4) 4 (15.4) 10 (38.5) 6 (23.1) 2 (7.7) <0.001
IFG/T2D2 45 (6.8) 5 (11.1) 8 (17.8) 9 (20.0) 21 (46.7) 2 (4.4) <0.001 48 (5.0) 9 (18.8) 8 (16.7) 20 (41.7) 8 (16.6) 3 (6.2) <0.001
Hypertension3 203 (30.5) 37 (18.2) 21 (10.3) 58 (28.6) 59 (29.1) 28 (13.8) <0.001 229 (23.9) 35 (15.3) 24 (10.5) 101 (44.1) 43 (18.8) 26 (11.4) <0.001
Weight status4               
Normal weight 314 (47.2) 195 (62.1) 38 (12.1) 33 (10.5) 32 (10.2) 16 (5.1)   279 (29.2) 185 (66.3) 38 (13.6) 28 (10.0) 15 (5.4) 13 (4.7)  
Overweight 243 (36.5) 95 (39.1) 41 (16.9) 54 (22.2) 44 (18.1) 9 (3.7)   319 (33.3) 157 (49.2) 60 (18.8) 71 (22.3) 22 (6.9) 9 (2.8)  
Obese 109 (16.4) 27 (24.8) 21 (19.3) 29 (26.6) 24 (22.0) 8 (7.3) <0.001 359 (37.5) 109 (30.4) 80 (22.3) 122 (33.9) 33 (9.2) 15 (4.2) <0.001
Waist-hip-ratio5               
Normal 414 (62.2) 280 (67.6) 58 (14.0) 40 (9.7) 29 (7.0) 7 (1.7)   615 (64.3) 340 (55.3) 118 (19.2) 116 (18.9) 29 (4.7) 12 (1.9)  
Elevated 252 (37.8) 37 (14.7) 42 (16.7) 76 (30.2) 71 (28.2) 26 (10.3) <0.001 342 (35.7) 111 (32.5) 60 (17.5) 105 (30.7) 41 (12.0) 25 (7.3) <0.001
Waist circumference6               
Normal 485 (72.8) 287 (59.2) 64 (13.2) 65 (13.4) 52 (10.7) 17 (3.5)   258 (27.0) 185 (71.7) 40 (15.5) 21 (8.1) 8 (3.1) 4 (1.6)  
Increased risk 98 (14.7) 23 (23.5) 17 (17.4) 23 (23.5) 28 (28.6) 7 (7.1)   215 (22.5) 113 (52.6) 33 (15.4) 43 (20.0) 15 (7.0) 11 (5.1)  
Elevated 83 (12.5) 7 (8.4) 19 (22.9) 28 (33.7) 20 (24.1) 9 (10.8) <0.001 484 (50.6) 153 (31.6) 105 (21.7) 157 (32.4) 47 (9.7) 22 (4.6) <0.001
  1. 1FCG > =7.0 mmol/l and /or on diabetes medication.
  2. 2FCG > =6.1 mmol/l and /or on diabetes medication.
  3. 3SBP ≥ 140 and /or DBP ≥ 90 mmHg and / or on hypertensive medication.
  4. 4Normal weight (18.5Kg/m2 ≤ BMI < 25Kg/m2), overweight (25Kg/m2 ≤ BMI < 30Kg/m2) and obese (BMI ≥ 30Kg/m2).
  5. 5Normal waist-hip-ratio < 1.0 for men and <0.85 for women and elevated waist-hip-ratio >1.0 for men and >0.85 for women.
  6. 6Normal waist circumference < 94 cm for men and <80 cm for women, increased risk (94 cm > WC < 102 cm) for men and (80 cm > WC < 88 cm) for women and elevated ≥102 cm for men and ≥ 88 cm for women.